A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
J Opioid Manag
; 10(6): 423-36, 2014.
Article
in En
| MEDLINE
| ID: mdl-25531960
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxycodone
/
Chronic Pain
/
Analgesics, Opioid
/
Naloxone
/
Narcotic Antagonists
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Aged80
Country/Region as subject:
America do norte
Language:
En
Journal:
J Opioid Manag
Journal subject:
NEUROLOGIA
/
PSICOFISIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2014
Type:
Article